A new machine-learning tool used by Citadel and Balyasny to rank their brokers hopes to put an end to the 'old boys network'

OpenFin is unveiling an app store for old-school Wall Street traders in a bid to become the iCloud of banking

Dakin Campbell | OpenFin CEO Mazy Dar was this week named one of Business Insider's 10 people transforming finance.

Read More »

The research chief at the world's largest hedge fund unpacks a market that's suddenly opening up to US investors — and why the gold rush is a once-in-a-lifetime opportunity

Akin Oyedele | "You're not going to get a lot of opportunities where such a large market opens up," Bridgewater's Karen Karniol-Tambour said.

Read More »

The lawyer who led Canopy Growth's groundbreaking $3.4 billion purchase of US marijuana cultivator Acreage Holdings says it will 'untap the market' for companies hunting similar deals

Jeremy Berke | The deal sent a shockwave through the cannabis industry and may pave the way for big consumer and pharma companies to get in on the US cannabis craze.

Read More »

GOLDMAN SACHS: A trade crucial for stock-market survival is the cheapest it's been since before the financial crisis. Here's how you can get involved.

Joe Ciolli | Stocks may seem calm right now as they approach their record high, but that's exactly the time traders should be seeking hedges at discount prices.

Read More »

This top-ranked wealth manager for the ultrarich rarely trades stocks, even when the market is in turmoil. Here's why.

Marley Jay | The acclaimed wealth manager Brian Pfeifler of Morgan Stanley tells what young investors can learn from his choice to rarely trade the stocks he buys.

Read More »

'Vulnerable to catastrophe': One market bear explains why stocks will crash 30% by the end of 2019 — and then flatline for the next 12 years

Joe Ciolli | The renowned market bear John Hussman lays out why he thinks the S&P 500 is in for a tough, money-losing road ahead.

Read More »

A Jeff Bezos-backed startup just inked a deal with $84 billion biotech Gilead to make drugs for a troubling and increasingly common disease

Erin Brodwin | Insitro and Gilead are teaming up to create drugs for a liver disease affecting millions. The startup is backed by Jeff Bezos and Andreessen Horowitz.

Read More »

People frustrated with their taxes are piling a record amount of money into an exempt investment that looks unstoppable. Here's how you can get involved.

Marley Jay | Wells Fargo says President Donald Trump's Tax Cuts and Jobs Act set off a rally in income-tax-free municipal bonds that's showing no signs of slowing.

Read More »

2 of America's most acclaimed wealth managers for the ultrarich explain why a famous approach to retirement investing is dead wrong — and reveal what people should do instead

Marley Jay | Jeff Erdmann of Merrill Lynch and Peter Mallouk of Creative Planning, two of America's best wealth managers, dispel a myth about retirement investing.

Read More »